IP Library Granted Patent US 8,131,374
Granted Patent B2
US 8,131,374 · App. 13/204,022 · Granted Mar 6, 2012

Electrical nerve stimulation device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,131,374
App. No.
13/204,022
Granted
Mar 6, 2012
Kind
B2
Abstract

The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.

Claims (32)

1. A method of monitoring patient compliance for implementation with an electrical nerve stimulation device, the method comprising the steps of:

generating an output treatment signal to at least one output channel having at least one lead wire with an electrode for attachment to the skin tissue of a patient;

monitoring at a controller the actual delivery of the generated output treatment signal to the patient by polling the at least one output channel for an open lead condition; and

storing selected data representing patient compliance at non-volatile memory, wherein the data includes a plurality of compliance data including compliance data dependant upon sensed changes in the actual delivery of the output treatment signal to the patient.

2. The method of claim 1 , further including downloading at least the compliance data at a communication port.

3. The method of claim 2 , wherein the downloading of the compliance data includes downloading a patient usage timer and a device usage timer.

4. The method of claim 3 , wherein the downloading of the compliance data further includes downloading a plurality of independent modality usage timers.

5. A method of using an electrical nerve stimulation device, comprising the steps of:

inputting at least one operating parameter into the nerve stimulation device at a keypad;

processing the at least one inputted operating parameter to generate an output pulse signal at an at least one output channel; and

monitoring changes in the actual delivery of the generated output signal to a user through polling of the at least one output channel.

6. The method of claim 5 , further comprising storing time accumulators in non-volatile memory for use in monitoring patient compliance.

7. The method of claim 6 , further including downloading the time accumulators at a communication port.

8. The method of claim 7 , further including uploading software to the device at a communication port, wherein the software controls, processes, and monitors operation of the device.

9. The method of claim 5 , wherein monitoring changes in the delivery of the generated output signal further includes adjusting the output signal at the at least one output channel to a low level polling signal upon detection of an open lead condition.

10. The method of claim 9 , further including setting the output signal to approximately zero upon detecting the removal of the open lead condition, and then gradually stepping up the output signal to substantially the level maintained prior to detection of the open lead condition.

11. The method of claim 5 , further including periodically monitoring the voltage capacity of a high voltage level power system controlling output through the at least one channel, wherein an ideal voltage capacity is substantially maintained during operation to obtain the generated output pulse signal.

12. A method of monitoring a high voltage level circuit in a nerve stimulation device to conserve battery power, the method comprising the steps of:

processing data, including inputted treatment parameters, to calculate a required electrical treatment output;

processing the calculated electrical treatment output to further calculate an ideal voltage level needed at a high voltage circuit to obtain the required electrical output;

generating the required electrical output for communication through at least one output channel;

periodically monitoring the ideal voltage level at the high voltage circuit; and

substantially maintaining the ideal voltage level at the high voltage circuit if it measurably deviates to reduce overcharging of the high voltage circuit.

13. The method of claim 12 , wherein the step of substantially maintaining the ideal voltage at the high voltage circuit includes communicating pulses to the high voltage circuit to replace pulses utilized in generating the required electrical output.

14. A method of operation for an electrical nerve stimulation device, comprising the steps of:

inputting at least one operating parameter into the nerve stimulation device;

processing the at least one inputted operating parameter to generate an output pulse signal at an at least one output channel;

monitoring changes in the delivery of the generated output signal to a user's skin through polling of the at least one output channel;

initiating a low polling signal to replace the generated output signal upon detecting an open lead condition at the at least one channel; and

performing a soft recovery ramp up of the output signal when the open lead condition is removed such that the low polling signal is set to approximately zero and the output signal is ramped up to a level substantially equal to the output signal generated prior to the open lead condition.

15. The method of claim 14 , wherein the output signal is ramped up to a level substantially equal to the output signal generated prior to the open lead condition within a predetermined period of time.

16. The method of claim 15 , wherein the predetermined period of time is some time less than 3 seconds.

Assignments (15)
SECURITY INTEREST Recorded Jan 3, 2024
From: DJO, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066186/0659 →
MERGER Recorded Oct 28, 2020
From: ENCORE MEDICAL ASSET CORPORATION
To: DJO, LLC
Reel/Frame 054201/0368 →
RELEASE OF SECURITY INTEREST Recorded Mar 21, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048672/0661 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 050129/0262 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: MACQUARIE US TRADING LLC AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048655/0067 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS THIRD LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048608/0932 →
RELEASE OF SECURITY INTEREST Recorded May 18, 2015
From: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC; EMPI, INC.
Reel/Frame 035706/0457 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: MACQUARIE US TRADING LLC, AS COLLATERAL AGENT
Reel/Frame 035707/0398 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 035707/0454 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS THIRD LIEN AGENT
Reel/Frame 035707/0498 →
SECURITY INTEREST Recorded May 7, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS THE COLLATERAL AGENT
Reel/Frame 035614/0001 →
SECURITY AGREEMENT Recorded Apr 20, 2012
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RICKO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 028078/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2011
From: MOORE, GARY L.; CZECH, JOHN; WOLDEGIORGES, BISRAT; KARAS, MICHAEL
To: REHABILICARE, INC.
Reel/Frame 027013/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2011
From: COMPEX TECHNOLOGIES, INC.
To: ENCORE MEDICAL ASSET CORPORATION
Reel/Frame 027013/0317 →
MERGER Recorded Oct 4, 2011
From: REHABILICARE INC.
To: COMPEX TECHNOLOGIES, INC.
Reel/Frame 027013/0281 →